BillionToOne

BillionToOne is a precision diagnostics company focused on improving healthcare through accurate and accessible molecular diagnostics. Their proprietary technology, Quantitative Counting Templates (QCTs), allows them to count DNA molecules with single base-pair precision, enabling them to develop unique tests that push the boundaries of molecular diagnostics. BillionToOne's primary focus is on prenatal and oncology testing, offering a range of products like the UNITY Fetal Risk Screen, the first and only prenatal test to assess risk for aneuploidies and recessive conditions from a single maternal blood draw, and the Northstar Select and Northstar Response liquid biopsy tests for therapy selection and monitoring in oncology.

BillionToOne has a strong commitment to innovation, research, and patient-centricity. They have made significant strides in expanding their product portfolio and securing funding, showcasing their dedication to improving healthcare and creating a lasting impact on the future of molecular diagnostics. They prioritize building a positive and supportive workplace culture that attracts and retains top talent, allowing them to continue to innovate and deliver groundbreaking diagnostic solutions.

BillionToOne offers a range of job flexibility options to accommodate diverse needs and preferences. The company has open positions in both Menlo Park and Union City, California, as well as remote opportunities, providing flexibility in location. While the company emphasizes a collaborative and supportive work culture, it also values individual growth and personal fulfillment, offering generous benefits such as four months of paid family leave and a focus on family bonding. These benefits create a supportive environment where employees can prioritize both their careers and personal lives.

BillionToOne offers a comprehensive benefits package designed to support its employees' well-being and work-life balance. They provide competitive pay, a retirement savings plan with company matching, generous parental leave, free snacks and lunches, a complimentary gym, and EV charging stations. Additionally, they foster an inclusive and transparent work culture with weekly town hall meetings and a leadership team that reflects their customer base.

BillionToOne is a precision diagnostics company focused on making molecular diagnostics more powerful, efficient, and accessible for all. Their mission is to improve disease detection by quantifying DNA molecules with their proprietary molecular counting platform, called Quantitative Counting Templates (QCTs). This technology empowers them to develop unique tests that redefine the possibilities of molecular diagnostics, particularly in the areas of non-invasive prenatal screening and liquid biopsy, ultimately aiming to remove the fear of the unknown by providing accurate, fast, and accessible healthcare.

BillionToOne promotes a culture of teamwork, transparency, and inclusivity. They value innovation and creativity, and encourage employees to grow and evolve both personally and professionally. They foster a welcoming and supportive environment, offering generous benefits, flexible work arrangements, and opportunities for collaboration across departments. The company emphasizes a patient-centric approach and prioritizes making a positive impact on healthcare.

BillionToOne prioritizes building a diverse and inclusive workplace, recognizing that different perspectives and experiences lead to better innovation and outcomes. They actively promote an open and transparent culture, with events like weekly town hall meetings, and ensure their leadership represents their diverse customer base. This includes having women leading teams in marketing, market access, sales, medical science, and product development.